4//SEC Filing
OXIGENE INC 4
Accession 0001209191-15-048129
$OTLCCIK 0000908259operating
Filed
May 28, 8:00 PM ET
Accepted
May 29, 9:10 PM ET
Size
5.6 KB
Accession
0001209191-15-048129
Insider Transaction Report
Form 4
OXIGENE INCOXGN
CHAPLIN DAVID
Chief Scientific Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2015-05-28+225,000→ 225,000 totalExercise: $1.43Exp: 2025-05-28→ Common Stock (225,000 underlying)
Footnotes (2)
- [F1]Dr. Chaplin was awarded options to purchase shares of OXiGENE, Inc. common stock, $0.01 par value per share (the "Stock Options"), pursuant to the OXiGENE, Inc. 2015 Equity Incentive Plan, as partial compensation for his services as Chief Scientific Officer.
- [F2]25% of the Stock Options vest immediately, and the remainder will vest in 36 substantially equal monthly installments beginning on the one month anniversary of the grant date.
Documents
Issuer
OXIGENE INC
CIK 0000908259
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000908259
Filing Metadata
- Form type
- 4
- Filed
- May 28, 8:00 PM ET
- Accepted
- May 29, 9:10 PM ET
- Size
- 5.6 KB